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Abstract
Electronic cigarettes (e-cigarettes)
present a novel method for nicotine
delivery that is reportedly
advantageous when compared to
traditional cigarette usage.
Manufacturers and consumers claim
reduced chemical exposure, decreased
symptom profiles, and efficacy in
smoking reduction and cessation
greater than conventional nicotine
replacement therapies (NRT).
However these products present new
challenges and concerns to legislators,
clinicians, and public health advocates.
Questions of authority in state and
federal legislation, establishing
product quality control, assessing
long-term studies on e-cigarettes and
quantifying usefulness in harm
reduction represent only a portion of
the many unanswered topics being
discussed. The purpose of this article is
to assess the literature on e-cigarettes
and establish perceptions and attitudes
on this controversial subject.

Introduction
Electronic cigarettes (e-cigarettes)
are a recent addition to the
marketplace of tobacco products,
fitting into the broader category
of electronic nicotine delivery

systems (ENDS).1,2 First patented
in the 1960s, manufacture of the
modern e-cigarette did not begin
until 2004 when Chinese company
Ruyan® produced a prototype
electronic device capable of
emulating the subjective experience
of smoking while delivering
nicotine in the absence of burning
tobacco.3 They began circulating
internationally as early as 20072008,3-5 gaining the reputation as
a safer alternative to conventional
cigarettes while offering a socially
acceptable way to mimic smoking
in smoke-free environments.
These products are designed to
resemble their conventional tobacco
counterparts but deliver nicotine
through vaporizing a humectant
carrier, the most common of which is
propylene glycol, and can be mixed
with flavorants.3,6-8 Devices consist
of a disposable nicotine-containing
cartridge, a heating element, a
flow trigger, battery, and LED light.
Nicotine along with the propylene
glycol humectant and any flavorants
are drawn from the cartridge towards
the heating element as the user
applies suction to the mouthpiece.
This activates the flow trigger and
exposes the contents of the cartridge
to the heating element, vaporizing
the nicotine solution into a mist that
is inhaled. The LED light serves as
an indicator for when the flow trigger
is open and mimics the burning
end of a tobacco cigarette. 3,9-12
ENDS sales in the United
States started as early as 2007,5
mostly with internet sales. As

popularity of these devices grew,
they started appearing in shops
and mall kiosks, drawing attention
of state and federal regulators
who established complicated
and non-uniform regulations on
e-cigarettes.6,11-21 While there are
claims reporting markedly less
chemical exposure compared to
tobacco cigarettes and suggesting
usefulness in smoking cessation
strategies,3,13,22-31 there remain many
issues to be addressed: questions
of legal authority, the absence of
consistent quality control, long-term
studies of safety, and usefulness
in nicotine harm reduction.
While attitudes towards ENDS
devices remain mixed, they are a
quickly evolving source of interest. A
search of NCBI’s PubMed database
using the search terms “e-cigarette”
and “electronic cigarette” yielded
102 and 495 search results,
respectively. The literature on the
subject remains equivocal in many
respects and subjective data is only
beginning to be published. What is
certain about electronic cigarettes
is that they pose a significant
area for continued research.

E-Cigarette Culture and
User Expectations
Electronic cigarettes are marketed
strongly in television, and movies.
These products are presented
as harmless devices that aid in
smoking cessation and find their way
onto shows such as ‘The Doctors’
and ‘The Late Show with David
Letterman.’ Advertisers market
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just as heavily to the celebrities as
they do to the common consumer,
going so far as to make e-cigarettes
gifts at the Grammy Awards.14
However, unique amongst other
tobacco products is the presence
e-cigarettes have on the internet.
By 2010, Google internet searches
for ENDS increased dramatically.
Fifty to seventy five percent of these
searches in the United States were
directed towards sites specifically
dedicated to selling these products15
and of the top Google search results
for e-cigarettes, eight of the first ten
were online distributors.11 Use has
even found its way onto the world’s
largest video sharing service, with a
survey of YouTube videos containing
e-cigarette users illustrating males
five times more often as females.32
An entire culture has sprung up
surrounding the use of e-cigarettes,
with users self-identifying as “vapors”
and enthusiastically embracing
activities related to the use of ENDS
and in some cases acting as what
one study referred to as unpaid

evangelicals.8,33 Internationally, the
United States has one of the most
informed populations regarding
e-cigarettes and those most likely to
have heard of e-cigarettes are white
males who are heavy smokers and
are young, educated, have higher
income, and have at least one close
friend who smokes tobacco.5,34-36 Use
has been reported to mirror similar
variables34 however other research
suggests that despite hearing of
such products less often than their
well-educated male counterparts,
female current smokers with less
than a high school education and
of lower socioeconomic status are
more likely to ever have tried an
e-cigarette.1 Those who try such
products usually are in their teens
or twenties but continued use
correlates with higher educational
status.5,34,36,37 Non-daily smokers
are, according to one study,34 twice
as likely to try e-cigarettes than
daily smokers and if perceived
to be less harmful than tobacco
cigarettes are over four times

more likely to try ENDS. Non-daily
smokers make use of e-cigarettes
more than daily smokers and both
use them more than those who
recently ceased tobacco use.34
Awareness of e-cigarettes is on the
rise, with a doubling of awareness
and a quadrupling of ever use
from 2009 to 20101 but use of
ENDS products occurs less often
in the Southwest United States
compared to other states.37
Adolescents between the ages of
11 and 19 have reported awareness
of e-cigarettes and among those
individuals eighteen percent have
expressed a willingness to try them.38
Use among middle and high school
students has approximately doubled
from 2011 to 2012 with about 1.78
million students in 2012 having ever
tried an e-cigarette.39,40 Furthermore,
while older users of e-cigarettes are
more likely to use these products
as a means for tobacco cessation,
college users do not appear to be
motivated by a desire to quit.41 A
South Korean study reports that
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among adolescents, in addition
to the propensity for males to try
e-cigarettes reported elsewhere34
other precipitating factors include
peer influence, dissatisfaction in
school life, and a previous history
of cigarette use.35 This growing
trend of e-cigarette experimentation
among minors presents concerns
of e-cigarettes serving as gateways
to nicotine addiction.5,38
Users of e-cigarettes cite
numerous reasons for their
continued use and most report
overall satisfaction with their
devices.42 Chief among these
is the belief that e-cigarettes
present a reduced risk of harm
when compared to tobacco
cigarettes.3,7,34,36,42 E-cigarettes are
perceived to decrease tobacco
cigarette use 3,8,36 and ultimately
maintain tobacco cessation and
abstinence in a large number of
cases.3,7,8,42 The biobehavioral
feedback mechanisms simulated by
vaping, the term for smoking an ecigarette, are also cited as reasons
for e-cigarette use, noting that these
devices are able to address the oral
fixation seen in current and former
smokers, successfully mimicking
the sensation of smoke against the
throat (a term called “throat-hit”),
copying the gestures and actions
seen in conventional cigarette use,
and alleviating symptoms of craving
and withdrawal.3,8,33,42 Numerous
health benefits are attributed
to a transition from tobacco to
e-cigarettes including respiratory
improvement, decreased cough,
reduced weight gain after tobacco
cessation, and increased exercise
tolerance.3,8 Smokers also highlight
reductions in loss of smell and taste,
the avoidance of tobacco odor on
clothing, and absence of smoker’s
breath.3,8 Less significant reasons
are absence of any open flames
during product use, cheaper overall
price, avoiding bothering other
people with cigarette smoke, dealing
with smoke free situations, and
serving as a complete alternative
to smoking.3,7,42 Not all reasons
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cited for the use of ENDS products
are a reduction in negative effects
of tobacco products. Many users
reported positive aspects of ENDS
usage including social benefits
through a sense of belonging to an
online vaping community, hobby
elements as users purchase and
customize their e-cigarettes, and
establishing a sense of personal
identity in calling themselves
vapers.15,33 Many e-cigarette users
enjoy modifying (or “modding”)
their products to include larger
batteries for fewer charges between
uses or to sustain larger amounts
of vapor for larger throat hits.8
While users are quick to point out
that these devices can help achieve
a successful nicotine taper, they
are firm in drawing the distinction
between smoking cessation and
nicotine cessation. Eliminating the
harmful effects of cigarettes while
still maintaining the ‘good’ effects
of nicotine is seen by users as a
desirable outcome.33 Although similar
to the goals of conventional nicotine
replacement therapies (NRT) and
in many instances used similarly by
former smokers to avoid relapses
or to bolster smoking cessation,42
users of ENDS report a stronger
preference to the e-cigarette with
fewer reported side effects.7,8,33,42

Positive Data Findings on
E-Cigarettes
Although there is relatively little
data to objectively lend credibility
to assertions of harm reduction,
the data available does show
promise. Whereas up to 80% of
individuals who use conventional
NRT for smoking cessation return to
smoking by one year,9 e-cigarettes
may help reduce the number
of cigarettes smoked, maintain
abstinence at six months after initial
purchase, and reduce dependence
on nicotine.22 While some studies
report only modest improvements,
likening their use to nicotine
patches23 smokeless tobacco
including e-cigarettes is reported
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to be 90-99% less deadly than
tobacco cigarettes18 and effective
at delivering nicotine into the blood,
decreasing withdrawal symptoms
associated with smoking cessation.24
E-cigarettes may decrease tobacco
cigarette consumption in those who
have no intention to quit smoking
while maintaining a reduced side
effect profile compared to tobacco
cigarettes.1,3,25-31 Interestingly,
the abstinence induced by these
products seems to be irrespective
of nicotine concentration25 once
again strengthening the possible
explanation that this is due to the
biobehavioral feedback mechanisms
mimicked in e-cigarettes compared
to other forms of NRT.3,31
Furthermore, e-cigarettes have
been effective in treating patients
who are refractory to all other
forms of tobacco cessation.43
Public health has also seen
improvements with e-cigarettes.
In Sweden the introduction of
smokeless tobacco products
including e-cigarettes has greatly
decreased smoking related
fatalities.13 American studies also
report the public health benefits of
e-cigarettes as a harm reduction
strategy compared to traditional
tobacco cigarette usage.3,4,31,44
These series of studies admit it may
be premature to make sweeping
conclusions, but they feel that there
are no serious health concerns when
compared to traditional cigarette use
due to drastic reductions in harmful
toxicants by an order of anywhere
from 9-450%.44 Analyses of
e-cigarette vapor yielded reductions
in nicotine, carbon monoxide,
tobacco specific nitrosamines (TSN)
including N’-nitrosonornicotine
(NNN), N’nitrosoanatabine (NAT),
N’nitrosanabasine (NAB), and
4-(methylnitrosamino-1-(3-pyridyl)1-butanone (NNK), carbonyl
compounds including formaldehyde,
acetaldehyde, acrolein, and
o-methylbenzaldehyde, volatile
organic compounds such as toluene
and pim-xyline, the metals cadmium,
nickel, and lead, and polyaromatic
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Schematic of Average Electronic Cigarette The average e-cigarette contains six essential parts: first, a heating unit vaporizes
nicotine-containing humectant responsible for the formation of the aerosolized nicotine and optional flavorants. It is controlled by a
sensor and microprocessor which are involved in detecting the suction applied by the user and regulating the heating of the humectant.
The solution is contained in a disposable or refillable cartridge and a battery source provides the necessary energy for aerosolizing the
fluid. Lastly, an LED light is often placed at the end of the device to simulate the visual queue of a cigarette burning during suction and
to notify others that the device is in use.

hydrocarbons.44,45 When compared
to the emissions found in tobacco
cigarettes, authors of these
articles claim these levels pose no
apparent risk to human health.45

Negative Data Findings on
E-Cigarettes
While there may be benefits to
e-cigarette usage, there are still
drawbacks and consequences.
Currently e-cigarettes lack regulation
of manufacture, enforcement of
sanitary conditions, guidelines in
handling pharmaceutical-grade
ingredients, and incomplete or
absent listing of constituents.3 The
most egregious of these offenses
is the lack of quality control, with
brands having wildly different
concentrations of nicotine.46,47
Products listed as having no nicotine
reveal significant concentrations

upon analysis.3,6,48 There are even
products claiming to possess
E-Cialis (tadalafil) and rimonobant
for erectile dysfunction and dieting,
respectively, without ever assessing
the validity or safety of such
claims.48 Among the chemicals
known to be present in e-cigarettes,
propylene glycol presents possible
carcinogenic concerns 6 and initial
exposure causes sore throat, dry
cough, and dizziness.3,49 Other
humectants such as glycerin and
diethylene glycol, not advertised
as present in e-cigarettes, are also
found and present health concerns
in poorly quality controlled settings,6
however the FDA reports that in the
measurements it has made on a
limited number of products it has not
found lethal concentrations of these
substances.3 Other miscellaneous
irritants including butyl acetate,
diethyl carbonate, benzoic acid,

www.wvsma.org

quinolone, dioctyl phthalate, and
2,6-dimethyl phenol were also
found as unlisted ingredients but
have unclear significance.6 “Passive
vaping,” a form of second-hand
smoke for e-cigarettes, has also
been confirmed however it too
is in early stages of study.50
Additional product concerns
include fluid leaks from cartridges,
difficulties assembling apparatuses
without spilling nicotine fluid, poor
labeling, poor or absent instruction
on how to properly dispose of spent
cartridges, failed safety features,
baseless claims, and errors in
filling orders.6,10 Furthermore,
whereas traditional cigarettes
have only 1-2 mg of nicotine each,
nicotine cartridges carry far greater
concentrations. With lethal doses
of nicotine anywhere from 30-60
mg, there is concern that children or
even adults may accidentally expose
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themselves to fatal overdoses if not
properly handling their devices.6,17,51
Of concern is the use of
e-cigarettes among children and
populations heretofore abstinent
from nicotine products. Companies
have been known to distribute free
samples9 and there are concerns
that these will encourage novices
to become addicted to what they
perceive as a safer smoking
product.4 Children are targeted
for addiction with the addition of
flavorants including strawberry and
chocolate to mask the otherwise
bitter taste of the product.6,38-40

Legislation
Currently e-cigarettes are in a
state of legal ambiguity. The FDA
met resistance from the DC Circuit
Court in the 2011 case Sottera Inc.
v. FDA, in which the court ruled that
e-cigarette regulation at the federal
level is outlined according to the
2009 Family Smoking Prevention
and Tobacco Control Act and not the
Federal Food, Drug, and Cosmetic
Act (FDCA). While the FDA
attempted to regulate and control
the sale of e-cigarettes, claiming
they were in fact misbranded
drug device combinations and
thus deserving of regulation as
medical devices, Sottera Inc.
successfully appealed that the
FDA can only regulate tobacco
products marketed as therapeutic.
In so doing, the court prohibited
the FDA’s ability to effectively
regulate these devices, drastically
hindering any efforts to ensure
quality control or safety.11,12,16,19 It
took three years to overcome this
setback, but, in April 2014, the
FDA proposed a rule to extend
their authority to include regulation
of additional tobacco products
including e-cigarettes. Importantly,
the new rule would allow the FDA
to prohibit free samples, limit the
sale of the products to adults, and
limit any health claims to those
supported by scientific evidence.52
States have been able to take
local action to regulate the sale and
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use of e-cigarettes to a degree,
mirroring laws in place for traditional
tobacco products. California, Utah,
and New Jersey do not allow the
sale of ENDS to minors and Oregon
does not sell ENDS at all. New
Jersey and New York ban the sale
and public use of the devices.11
The United States Air Force bans
the devices on their premises.14

Presently there is a scarcity
of trials with long term follow
up of e-cigarette use 3 and an
absence of nonclinical, animal,
clinical, and public health studies
to draw sufficient conclusions
to make definitive statements.52
Until these studies are performed,
clinicians should advise patients
that there is not enough evidence
to definitively say that these
products are safe or effective to
use for smoking cessation.2
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CME Post-Test
1. Awareness of e-cigarettes in the US
quadrupled from 2009-2010
True

False

3. Use among middle school and high school students
ever trying e-cigarettes doubled from 2011-2012
True

False

2. Forty to fiffty-five percent of Google searches for
e-cigarettes are for sites selling the devices
True

False

Invitation for Submissions to
a Vignette Series

Compassion in Medicine
The West Virginia Medical Journal (WVMJ) is soliciting vignettes from West Virginia physicians, who have
practiced in the state for at least 10 years. Vignettes
should highlight experiences in which their patient care
inspired or educated the author in a meaningful way.
Submissions are limited to 700 words. Please accompany your submission with a cover letter, including your
name, address, email address, title and employment af-
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filiation and years in practice. Submissions are open to
all West Virginia physicians.
Vignettes will be published periodically throughout the
year, without specific notice of a scheduled publication date. Please be sure the submission contains no
identifiable patient information. Only one submission
per author.
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